Health
Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses – News-Medical.Net
Now, a new study published in the preprint server bioRxiv in July 2020 reports on the antiviral activity of two drugs found in an antimalarial drug currently in phase II trials in South Korea, called Pyramax.
The COVID-19 pandemic has taken a massive toll on human life, with the virus spreading to 188 countries and territories and infecting nearly 17 million individuals. A very significant source of uncertainty in dealing with the pandemic has been the lack of any effective antiviral or vaccine against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) despite strenuous scientific efforts.
Now, a new study published in the preprint server bioRxiv* in July 2020 reports o…
-
Noosa News8 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News13 hours agoLarge fleet of Robinson R22 helicopters sold as HM Air flies in another direction
-
General6 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News7 hours agoLyka Doggie Date Night at Moonlight Cinema